About BioConsortia
BioConsortia is a company based in Davis (United States) founded in 2014. BioConsortia has raised $56 million across 7 funding rounds from investors including Khosla Ventures, Square 1 Bank and Otter Capital. BioConsortia offers products and services including Nitrogen Fixation, Biostimulants, and Biopesticides. BioConsortia operates in a competitive market with competitors including Pivot Bio, Ginkgo Bioworks, NewLeaf Symbiotics, Kula Bio and Pluton Biosciences, among others.
- Headquarter Davis, United States
-
Sectors
Chemicals & MaterialsAgriculture
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bioconsortia, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$56 M (USD)
in 7 rounds
-
Latest Funding Round
$15 M (USD), Series E
Apr 01, 2024
-
Investors
Khosla Ventures
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BioConsortia
BioConsortia offers a comprehensive portfolio of products and services, including Nitrogen Fixation, Biostimulants, and Biopesticides.
Microbial solutions for natural nitrogen production in crops
Products to boost crop growth and stress resistance
Microbes for protecting crops from pests and fungi
People of BioConsortia
Unlock access to complete
Funding Insights of BioConsortia
BioConsortia has successfully raised a total of $56M across 7 strategic funding rounds. The most recent funding activity was a Series E round of $15 million completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in BioConsortia
BioConsortia has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Khosla Ventures, Square 1 Bank and Otter Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Limited information is provided about Otter Capital's activities.
|
Locked | Locked | Locked | |
|
Early-stage startups are funded by this venture capital firm.
|
Locked | Locked | Locked | |
|
Venture debt, treasury, and cash management services are provided.
|
Locked | Locked | Locked |
Investor details for BioConsortia
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BioConsortia
Investment portfolio details for BioConsortia
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BioConsortia
Detailed financials for BioConsortia
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bioconsortia Comparisons
Peer comparison for BioConsortia
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BioConsortia
BioConsortia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pivot Bio, Ginkgo Bioworks, NewLeaf Symbiotics, Kula Bio and Pluton Biosciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Nitrogen-fixing microbes for corn crop nutrition are developed and applied.
|
|
| Locked | Locked | Locked |
Gene editing-based cultured ingredients are provided for agriculture.
|
|
| Locked | Locked | Locked |
Crop inputs are supplied using beneficial plant bacteria for agriculture.
|
|
| Locked | Locked | Locked |
Manufacturer of microbial crop nutrition products
|
|
| Locked | Locked | Locked |
Assay-based microbial research services are offered for industrial applications.
|
Detailed competitors of BioConsortia
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bioconsortia
Complete news archive for BioConsortia
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioConsortia
BioConsortia was founded in 2014.
BioConsortia is headquartered in Davis, United States. It is registered at Davis, California, United States.
BioConsortia is a funded company, having raised a total of $56M across 7 funding rounds to date.
BioConsortia was established in 2014 in Davis, United States, within the biotechnology sector focused on agriculture. Microbial technologies are utilized to create products that improve fertilizer efficiency, promote plant growth, and enhance traits such as tolerance to cold, wet conditions, salt, and drought. A proprietary platform based on high-throughput sequencing is applied to identify microbes that benefit plant performance. Operations center on developing these solutions for crop improvement.
BioConsortia's top competitors include Ginkgo Bioworks, Pivot Bio and Kula Bio.
BioConsortia offers Nitrogen Fixation, Biostimulants, and Biopesticides.
BioConsortia has 3 investors. Key investors include Khosla Ventures, Square 1 Bank, and Otter Capital.